SV

Street Verdict

Analyst Scorecard

ZYDUSWELL · NSE

Zydus Wellness Limited

₹448.05

-1.71% (-₹7.8)

Prev. close

₹455.85

Volume

1,40,918

Delivery %

44.4%

As of

20 Nov 2026

Price history

₹448.05-₹48.6 (-9.79%) · 3M
18 Aug 2026 → 20 Nov 2026
46048050052054056018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

Analysts lean bullish

1 analyst stance · last 90 days · one per analyst

Trackable

1 · 1 bull / 0 neutral / 0 bear

Long-Horizon

none in range

Commentary

none in range

Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded

Bullish 100% (1)Neutral 0% (0)Bearish 0% (0)
Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions

Fundamentals

About Zydus Wellness Limited

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America. It provides glucose powder under the Glucon-D brand; sugar substitute products under the Sugar Free Gold+, Sugar Free Natura, Sugar Free Green, and I'm lite brands; Milk-based nutrition drink products under the Complan brand; table spreads under the Nutralite brand; skin cleansing products under the Everyuth brand; hair color products under the Cuticolor brand; heat powder under the Nycil brand; and healthy eating products, such as snack bars, protein bars, breakfast cookies, and protein chips under the RiteBite brand. The company also offers plant-based supplements, vitamins and minerals, collagens, omegas, probiotics, and micronutrients for adults under the WeightWorld brand; health and wellness products, including multivitamin and vitamin D3 gummies, mushroom-based supplements, and other superfood supplements under the MaxMedix brand; and food supplements for dogs and cats under the Animigo brand. The company was formerly known as Carnation Nutra-Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited operates as a subsidiary of Zydus Lifesciences Limited.

Details

Sector

Consumer Defensive

Industry

Packaged Foods

CEO

Mr. Tarun G. Arora

Headquarters

Ahmedabad

Employees

1,685

Key stats

Market cap

₹15,551.69 Cr

P/E ratio (TTM)

63.2

Dividend yield

0.25%

EPS (TTM)

₹7.74

Beta (1Y · daily vs NIFTY 50)

0.59

Beta (5Y · monthly vs NIFTY 50)

0.47

Shares float

9.35 Cr

EPS · quarter ended Jun 2026

₹3.74

Financial Performance

01 · Financials

0 Cr1000 Cr2000 Cr3000 Cr4000 Cr₹0%5%10%15%20%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

051015₹FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

0112₹-100%-50%0%50%19 Mar 2014 Jul 2114 Jul 2221 Jul 2319 Jul 2411 Jul 2517 Jul 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

-50%0%50%100%FY21FY22FY23FY24FY25FY26
SalesFixed assetsReceivables (trade + unbilled)Inventory

05 · Capital Structure & Asset Utilization

0 Cr5000 Cr10000 Cr15000 Cr₹0×0.2×0.4×0.6×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr5000 Cr10000 Cr15000 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

0 Cr1000 Cr2000 Cr3000 Cr4000 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹1,866.67 Cr₹2,009.10 Cr₹2,254.79 Cr₹2,327.80 Cr₹2,708.90 Cr₹3,961.00 Cr
EBITDA
₹221.17 Cr₹355.15 Cr₹331.96 Cr₹307.90 Cr₹399.20 Cr₹475.30 Cr
₹118.73 Cr₹308.87 Cr₹310.40 Cr₹266.90 Cr₹346.90 Cr₹197.20 Cr
Diluted EPS
₹3.91₹9.71₹9.76₹8.39₹10.9₹6.2

EBITDA for Mar 2021 could not be checked against the company's own annual report: this page shows ₹221.17 Cr while the annual report gives ₹353.30 Cr (59.7% apart). That disagreement leaves the whole cross-check inconclusive, so EBITDA for Mar 2020 (the annual report alone gives ₹331.77 Cr) is left blank here too, rather than shown from only one of the two sources.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹5,666.43 Cr₹5,692.18 Cr₹5,833.05 Cr₹6,148.40 Cr₹6,441.90 Cr₹10,307.80 Cr
₹550.40 Cr₹387.34 Cr₹297.30 Cr₹328.70 Cr₹188.30 Cr₹3,202.80 Cr
Stockholders' equity
₹4,567.79 Cr₹4,844.03 Cr₹5,122.65 Cr₹5,357.50 Cr₹5,671.60 Cr₹5,826.00 Cr

Long-term debt, Current (short-term) debt, Others have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹286.51 Cr₹236.85 Cr₹91.71 Cr₹246.40 Cr₹380.00 Cr₹226.40 Cr
Investing cash flow
₹-10.41 Cr₹-58.93 Cr₹-84.84 Cr₹-177.70 Cr₹-223.60 Cr₹-2,909.90 Cr
₹-216.21 Cr₹-233.82 Cr₹-138.49 Cr₹-25.70 Cr₹-186.30 Cr₹2,698.40 Cr
Capital expenditure
₹-19.66 Cr₹-75.44 Cr₹-44.96 Cr₹-28.50 Cr₹-66.30 Cr₹-101.70 Cr
End cash position
₹252.72 Cr—₹38.18 Cr₹80.00 Cr₹66.70 Cr₹110.60 Cr

Debt issued, Debt repaid, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemJun 21–Mar 22(4Q)Jun 22Sep 22–Dec 22(2Q)Mar 23Jun 23Sep 23Dec 23Mar 24–Dec 24(4Q)Mar 25–Mar 26(5Q)Jun 26
Promoter64.82%65.14%65.35%66.45%67.10%68.54%69.15%69.62%69.63%69.64%
Public35.18%34.86%34.65%33.55%32.90%31.46%30.85%30.38%30.37%30.36%
Employee trusts0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Consumer Defensive

Company
Hindustan Unilever Limited₹4.63 L Cr₹1,977.143.79.4930.9%0.03+5.3%-19.2%
ITC Limited₹3.51 L Cr₹28018.64.8428.5%0.03+4.8%-31.5%
Nestle India Limited₹2.41 L Cr₹1,24859.060.0380.0%0.29+19.6%-1.3%
Avenue Supermarts Limited₹2.21 L Cr₹3,41470.89.0312.1%0.10+16.0%-18.4%
Varun Beverages Limited₹1.42 L Cr₹420.45144.97.2415.5%0.13+7.1%-10.7%
Britannia Industries Limited₹1.18 L Cr₹4,946.345.323.0949.6%0.27+7.5%-16.1%
Marico Limited₹1.12 L Cr₹878.459.326.5241.9%0.13+26.2%+21.6%
TATA CONSUMER PRODUCTS LIMITED₹1.06 L Cr₹1,06862.24.857.1%0.13+15.2%-9.4%
United Spirits Limited₹99,954.50 Cr₹1,419.359.411.1620.5%0.05+7.8%-2.2%
Godrej Consumer Products Limited₹86,743.53 Cr₹84943.86.8614.7%0.35+8.5%-27.0%
Dabur India Limited₹69,627.81 Cr₹39535.46.1016.6%0.11+5.2%-23.6%
Zydus Wellness Limited₹15,696.46 Cr₹488.883.32.693.4%0.55+46.4%+5.6%

Ranked by market cap within Consumer Defensive, same metrics as the Fundamentals screener. Click a column to sort.

ZYDUSWELL

NCLT disposes of dissolution plea for Zydus Wellness' erstwhile subsidiary Naturell India

The Economic Times · 2 days ago

ZYDUSWELL

Zydus Wellness (NSE:ZYDUSWELL): Why Did NCLT Dispose of NIPL Dissolution Petition?

Kalkine India · 3 days ago